Meta‐analysis: Prevalence and impact of alcohol abstinence in alcohol‐associated cirrhosis
Alimentary Pharmacology & Therapeutics · 2024-03 · 59 (6) · 730-741
DOI: 10.1111/apt.17888 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2024-02. Verfasst von Wen Hui Lim und 19 weiteren Autor:innen. Beteiligte Einrichtung: Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Hauptthemen laut MEDLINE: Alcohol Abstinence, Liver Cirrhosis, Alcoholic. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIDDK NIH HHS, NIAAA NIH HHS.
Abstract (Originalsprache)
Background
Although alcohol abstinence may be an effective intervention for alcohol‐associated cirrhosis, its association with prognosis has not been systematically assessed or quantified.
Aims
To determine the prevalence of alcohol abstinence, factors associated with alcohol abstinence and the impact of abstinence on morbidity and overall survival in people with alcohol‐associated cirrhosis.
Methods
We searched Medline and Embase from inception to 15 April 2023 for prospective and retrospective cohort studies describing alcohol abstinence in people with known alcohol‐associated cirrhosis. Meta‐analysis of proportions for pooled estimates was performed. The method of inverse variance, employing a random‐effects model, was used to pool the hazard ratio (HR) comparing outcomes of abstinent against non‐abstinent individuals with alcohol‐associated cirrhosis.
Results
We included 19 studies involving 18,833 people with alcohol‐associated cirrhosis. The prevalence of alcohol abstinence was 53.8% (CI: 44.6%–62.7%). Over a mean follow‐up duration of 48.6 months, individuals who continued to consume alcohol had significantly lower overall survival compared to those who were abstinent (HR: 0.611, 95% CI: 0.506–0.738). These findings remained consistent in sensitivity/subgroup analysis for the presence of decompensation, study design and studies that assessed abstinence throughout follow‐up. Alcohol abstinence was associated with a significantly lower risk of hepatic decompensation (HR: 0.612, 95% CI: 0.473–0.792).
Conclusions
Alcohol abstinence is associated with substantial improvement in overall survival in alcohol‐associated cirrhosis. However, only half of the individuals with known alcohol‐associated cirrhosis are abstinent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore, Singapore.
- National University Centre for Organ Transplantation, National University Health System, Singapore, Singapore.
- School of Medicine, International Medical University, Kuala Lumpur, Malaysia.
- Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
- Liver Center, Saga Medical School, Saga University, Saga, Japan.
ORCID-Profile: Cheng Han Ng, Mark Muthiah, Karn Wijarnpreecha, Mazen Noureddin, Rohit Loomba, Daniel Q Huang
Förderung
- NCATS NIH HHS
- NIDDK NIH HHS
- NIAAA NIH HHS
- NHLBI NIH HHS
- National Center for Advancing Translational Sciences
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Heart, Lung, and Blood Institute
- National Institute on Alcohol Abuse and Alcoholism
Zitieren
APA
Lim, W. H., Tay, P., Ng, C. H., Tan, D. J. H., Ong, C., Koh, J. H., Teng, M., Chee, D., Wong, Z. Y., Kawaguchi, T., Takahashi, H., Muthiah, M., Tan, E. X. X., Wijarnpreecha, K., Lee, G. H., Noureddin, M., Lee, B. P., Mathurin, P., Loomba, R., & Huang, D. Q. (2024). Meta‐analysis: Prevalence and impact of alcohol abstinence in alcohol‐associated cirrhosis. Alimentary Pharmacology & Therapeutics, 59(6), 730-741. https://doi.org/10.1111/apt.17888
Vancouver
Lim WH, Tay P, Ng CH, Tan DJH, Ong C, Koh JH, et al. Meta‐analysis: Prevalence and impact of alcohol abstinence in alcohol‐associated cirrhosis. Alimentary Pharmacology & Therapeutics. 2024;59(6):730-741. doi:10.1111/apt.17888
BibTeX
@article{Lim2024,
author = {Lim, Wen Hui and Tay, Phoebe and Ng, Cheng Han and Tan, Darren Jun Hao and Ong, Christen and Koh, Jia Hong and Teng, Margaret and Chee, Douglas and Wong, Zhen Yu and Kawaguchi, Takumi and Takahashi, Hirokazu and Muthiah, Mark and Tan, Eunice X X and Wijarnpreecha, Karn and Lee, Guan Huei and Noureddin, Mazen and Lee, Brian P and Mathurin, Philippe and Loomba, Rohit and Huang, Daniel Q},
title = {Meta‐analysis: Prevalence and impact of alcohol abstinence in alcohol‐associated cirrhosis},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2024},
volume = {59},
number = {6},
pages = {730--741},
doi = {10.1111/apt.17888}
}
EUVIMED